Susquehanna International Group
PRAX icon

Susquehanna International Group’s Praxis Precision Medicines PRAX Stock Holding History

Susquehanna International Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Sell
35,900
-35,400
-50% -$11M ﹤0.01% 2897
2025
Q4 		$21M Sell
71,300
-30,100
-30% -$5.61M ﹤0.01% 2149
2025
Q3 		$5.37M Sell
101,400
-3,400
-3% -$165K ﹤0.01% 3965
2025
Q2 		$4.41M Sell
104,800
-6,000
-5% -$228K ﹤0.01% 4210
2025
Q1 		$4.2M Buy
110,800
+26,500
+31% +$1.65M ﹤0.01% 3993
2024
Q4 		$6.49M Buy
84,300
+20,300
+32% +$1.47M ﹤0.01% 3216
2024
Q3 		$3.68M Sell
64,000
-102,300
-62% -$5.53M ﹤0.01% 4158
2024
Q2 		$6.88M Buy
166,300
+154,400
+1,297% +$7.3M ﹤0.01% 2955
2024
Q1 		$726K Buy
+11,900
New +$534K ﹤0.01% 7620
2023
Q4 		– Sell
-2,520
Closed -$64.6K – 13090
2023
Q3 		$64.6K Buy
2,520
+1,213
+93% +$22.9K ﹤0.01% 11180
2023
Q2 		$22.5K Buy
+1,307
New +$20K ﹤0.01% 11607
2022
Q3 		– Sell
-4,260
Closed -$157K – 13921
2022
Q2 		$157K Buy
4,260
+3,367
+377% +$359K ﹤0.01% 10971
2022
Q1 		$137K Sell
893
-200
-18% -$41.1K ﹤0.01% 11636
2021
Q4 		$323K Buy
1,093
+360
+49% +$106K ﹤0.01% 10302
2021
Q3 		$203K Buy
+733
New +$199K ﹤0.01% 11454

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Susquehanna International Group's PRAX Position: Q1 2026 in Review

Susquehanna International Group increased its Praxis Precision Medicines (PRAX) stake by 264% in Q1 2026, buying an estimated $1.91M and bringing the position to 8,517 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #5454.

Susquehanna International Group first reported a position in PRAX in Q4 2021 and has held it in 17 quarters since. The position peaked at $12.2M in Q4 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Susquehanna International Group held 8,517 shares of Praxis Precision Medicines worth $2.74M as of Q1 2026.
  • Susquehanna International Group bought 6,174 Praxis Precision Medicines shares in Q1 2026, an estimated $1.91M.
  • Praxis Precision Medicines made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5454 holding.
  • Susquehanna International Group first reported a position in Praxis Precision Medicines in Q4 2021 and has held it in 17 quarters since.
  • Susquehanna International Group's Praxis Precision Medicines position peaked at $12.2M in Q4 2024.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.